Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Hair loss treatment caused more hair loss in a man.

Androgenetic alopecia can cause distress and lower quality of life.

Androgenetic alopecia is a condition causing noticeable hair loss, especially in middle age, which is more severe than normal balding.

DHT, a testosterone byproduct, causes male pattern baldness.

Androgenetic alopecia affects many people, impacting quality of life, and treatment focuses on reversing hair follicle miniaturization.

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

Hair loss is caused by genetics and hormones, diagnosed through examination and biopsy, and treated with medications or surgery.

Androgenetic alopecia is a common hair loss condition caused by testosterone effects on hair follicles, leading to thinner, shorter, and less pigmented hair, diagnosed using scalp dermoscopy and treated with topical minoxidil, antiandrogen agents, and 5-alpha reductase inhibitors.

Androgenic alopecia, a common hair loss condition, is linked to changes in androgen metabolism and genetics, and can be treated with finasteride and minoxidil, but these treatments are only fully effective in 10% of patients.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Hair loss in men is mainly caused by hormones and genes, and while current treatments can slow it down, they can't fully stop it.

Androgenetic alopecia is the most common type of non-scarring hair loss, especially in young males, and early diagnosis and treatment are important.

Androgenetic alopecia, a common hair loss condition, can be treated with topical minoxidil, oral finasteride, or oral spironolactone, and new treatments like platelet-rich plasma, low-level laser therapy, and janus-kinase inhibitors are being explored.

Androgenetic alopecia is common, affects self-image, and has no complete cure yet.

Topical minoxidil and oral finasteride are effective treatments for androgenetic alopecia.

Effective treatments for hair loss include minoxidil, 5α-reductase inhibitors, and personalized combination therapies.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

New understanding of hair loss could lead to better treatments.

Hair loss, known as androgenetic alopecia, is mainly caused by genetics, but also by hormone imbalances, shrinking hair follicles, inflammation, and environmental factors.

Male androgenetic alopecia (MAA) is a common, hereditary hair loss condition in men, linked to heart disease, and can be treated with minoxidil, finasteride, or hair transplantation.